Table 2.
Demographic and clinical data
| n = 141 | |
|---|---|
| Female, n (%) | 72 (51) |
| Age, years, mean (SD) | 65 (15) |
| BMI, mean (SD) | 27 (5) |
| Tumor status (%) | |
| Primary | 117 (83) |
| Recurrence | 24 (17) |
| Tumor location, n (%) | |
| Proximal | 110 (78) |
| Distal | 31 (22) |
| Sarcoma subtype, n (%) | |
| Liposarcoma | 56 (39.7) |
| Undifferentiated pleomorphic sarcoma | 27 (19.1) |
| Sarcoma NOS | 17 (12.1) |
| Leiomyosarcoma | 16 (11.3) |
| Myxofibrosarcoma | 9 (6.4) |
| Other | 16 (11.4) |
| Tumor grade, n (%) | |
| Low | 73 (51.8) |
| High | 68 (48.2) |
| Tumor depth, with relation to deep fascia | |
| Superficial | 40 (28.4) |
| Deep | 101 (71.6) |
| Microscopical margins, n (%) | |
| Intralesional | 12 (8.5) |
| Marginal | 88 (62.4) |
| Wide | 41 (29.1) |
| Tumor size, mean (SD), cm | 8 (6) |
| Wound closure, n (%) | |
| Direct | 89 (61.3) |
| Skin graft | 22 (15.6) |
| Reconstruction | 30 (21.3) |
| Radiotherapy, n (%) | |
| Preoperative | 10 (7.1) |
| Postoperative | 46 (32.6) |
| Chemotherapy, n (%) | 22 (15.6) |
| Complications, n (%) | |
| Minor | 11 (7.8) |
| Major | 23 (16.3) |
| Time since surgery, months, mean (SD) | 62 (38) |
n number of patients;SD standard deviation
Location: proximal (groin, buttock, thigh) and distal (knee, lower leg, foot and ankle)